Inovio has sealed a research collaboration agreement with the National Institutes of Health (NIH)’s Vaccine Research Center (VRC), to develop influenza vaccines. Under the agreement, VRC and Inovio
Sandoz has launched tacrolimus capsules, a generic equivalent of Prograf, in the US. Tacrolimus is an immunosuppressive treatment to help prevent rejection of a kidney or liver transplant.
Pharmasset has reported a net loss of $6.9m, or $0.25 per share, for the third quarter ended June 30, 2009, as compared to a net loss of $15.0m,
Intermedix has acquired the assets of HRA Medical Management (HRA) of San Diego. HRA has provided emergency physician and hospitalist billing services to medical practice groups for more
APP Pharmaceuticals (APP), a wholly-owned subsidiary of Fresenius Kabi, has received approval from FDA to market idarubicin hydrochloride injection in three dosage strengths (5mg/5mL, 10mg/10mL and 20mg/20mL). APP
AlphaRx has received China patent for its topical platform technology – Vehicle For Topical Delivery of Anti-Inflammatory Compounds. The platform is an integral part of the company’s clinical
SCG-Dow Group, a joint venture between The Dow Chemical Company (Dow) and Siam Cement Group (SCG), has said that the construction of specialty elastomers plant in the Asia
Eiger BioPharmaceuticals has initiated patient dosing in CLEAN-1 clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial, undergoing in centers in Australia and
Mylan has received FDA approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan Succinate Tablets, 25mg, 50mg and 100mg. Mylan’s Sumatriptan Succinate Tablets are the generic version
MSD India, a subsidiary of Merck and Co., is planing to expand its presence in the Indian market – reported Hindustan Times. The company is currently ascertaining possible
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.